Early detection of high oxidative activity in patients with adenomatous intestinal polyps and colorectal adenocarcinoma: Myeloperoxidase and oxidized low-density lipoprotein in serum as new markers of oxidative stress in colorectal cancer

Laboratory Medicine

Volumn 46, Issue 2, 2015, Pages 123-135

  Crespo Sanjuán, Jesús ^a   Calvo Nieves, María D ^a   Aguirre Gervás, Beatriz ^a   Herreros Rodríguez, José ^a   Velayos Jiménez, Benito ^a   Castro Alija, María J ^a   Muñoz Moreno, María F ^a   Sánchez, Diego ^b   Zamora González, Nuria ^a   Bajo Grañeras, Raquel ^b   García Centeno, Rosa M ^a   Cabrerizo, María E Largo ^a   Bustamante, María R ^a   Garrote Adrados, José A ^c  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b CSIC   (Spain)

^c HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

Author keywords

Antioxidants; Cancer biomarkers; Colorectal cancer; LDL oxidized; Myeloperoxidase; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; C REACTIVE PROTEIN; LIPID; LYCOPENE; MYELOPEROXIDASE; OXIDIZED LOW DENSITY LIPOPROTEIN; RETINOL; LOW DENSITY LIPOPROTEIN; PEROXIDASE;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; HUMAN; INTESTINE POLYP; LIPOPROTEIN BLOOD LEVEL; MALE; OXIDATION; OXIDATIVE STRESS; ADENOMATOUS POLYPOSIS COLI; ANALYSIS OF VARIANCE; BLOOD; COHORT ANALYSIS; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; METABOLISM; MIDDLE AGED; VERY ELDERLY;

ADENOMATOUS POLYPOSIS COLI; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; C-REACTIVE PROTEIN; COHORT STUDIES; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PEROXIDASE;

EID: 84949755568     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LMZJJU6BC86WUDHW     Document Type: Article

References (25)

1. Benson AB III. Epidemiology, disease progression, and economic burden of colorectal cancer. J Manag Care Pharm. 2007;13(6 Suppl C):S5-S18.
2. Ballinger AB, Anggiansah C. Colorectal cancer. BMJ. 2007;6;335(7622):715-718.
3. Leung EYL, Crozier JEM, Talwar D, et al. Vitamin antioxidants, lipid peroxidation, tumour stage, the systemic inflammatory response and survival in patients with colorectal cancer. Int. J. Cancer. 2008;15;123(10):2460-2464.
4. Conner EM, Grisham MB. Inflammation, free radicals, and antioxidants. Nutrition. 1996;12(4):274-277.
5. Agostinelli E, Dalla Vedova L, Belli F, Condello M, Arancia G, Seiler N. Sensitization of human colon adenocarcinoma cells (LoVo) to reactive oxygen species by a lysosomotropic compound. Int J Oncol. 2006;29(4):947-955.
6. Melichar B, Kalábová H, Krčmová L, et al. Serum homocysteine, cholesterol, retinol, α-tocopherol, glycosylated hemoglobin and inflammatory response during therapy with bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin. Anticancer Res. 2009;29(11):4813-4820.
7. Melichar B, Krcmová L, Kalábová H, et al. Serum retinol, alphatocopherol and systemic inflammatory response in metastatic colorectal carcinoma patients treated with combination chemotherapy and cetuximab. J Nutr Sci Vitaminol (Tokyo). 2010;56(4):222-226.
8. Tang F-Y, Cho H-J, Pai M-H, Chen Y-H. Concomitant supplementation of lycopene and eicosapentaenoic acid inhibits the proliferation of human colon cancer cells. J Nutr Biochem. 2009;20(6):426-434.
9. Pan M-H, Lai C-S, Wu J-C, Ho C-T. Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds. Mol Nutr Food Res. 2011;55(1):32-45.
10. Suzuki K, Ito Y, Wakai K, et al. Serum oxidized low-density lipoprotein levels and risk of colorectal cancer: a case-control study nested in the Japan Collaborative Cohort Study. Cancer Epidemiol Biomarkers Prev. 2004;13(11 pt 1):1781-1787.
11. van Duijnhoven FJB, Bueno-De-Mesquita HB, Calligaro M. et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut. 2011;60(8):1094-1102.
12. Esteve E, Ricart W, Fernández-Real JM. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr. 2005;24(1):16-31.
13. Avramoglu RK, Basciano H, Adeli K. Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta. 2006;368(1- 2):1-19.
14. Napoli C, de Nigris F, Palinski W. Multiple role of reactive oxygen species in the arterial wall. J Cell Biochem. 2001;82(4):674-682.
15. Poynter JN, Gruber SB, Higgins PDR, et al. Statins and the risk of colorectal cancer. N Engl J Med. 2005;26;352(21):2184-2192.
16. Cole BF, Logan RF, Halabi S, et al. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst. 2009;18;101(4):256-266.
17. Van Hoydonck PGA, Temme EHM, Schouten EG. A dietary oxidative balance score of vitamin C, β-carotene and iron intakes and mortality risk in male smoking Belgians J Nutr. 2002;132(4):756-761.
18. Goodman M, Bostick RM, Gross M, Thyagarajan B, Dash C, Flanders WD. Combined measure of pro- and anti-oxidant exposures in relation to prostate cancer and colorectal adenoma risk: an update. Ann Epidemiol. 2010;20(12):955-957.
19. Roncucci L, Mora E, Mariani F, et al. Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2008;17(9):2291-2297.
20. Wu Z-Y, Wan J, Zhao G, et al. Risk factors for local recurrence of middle and lower rectal carcinoma after curative resection. World J Gastroenterol. 2008;14;14(30):4805-4809.
21. Hogan AM, Collins D, Baird AW, Winter DC. Estrogen and gastrointestinal malignancy. Mol Cell Endocrinol. 2009;13;307(1-2):19-24.
22. Tabuchi M, Kitayama J, Nagawa H. Hypertriglyceridemia is positively correlated with the development of colorectal tubular adenoma in Japanese men. World J Gastroenterol. 2006;28;12(8):1261-1264.
23. Prizment AE, Anderson KE, Visvanathan K, Folsom AR. Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study. Cancer Epidemiol Biomarkers Prev. 2011;20(2):297-307.
24. Luo W, Cao Y, Liao C, Gao F. Diabetes mellitus and the incidence and mortality of colorectal cancer: A meta-analysis of twenty four cohort studies. Colorectal Dis. 2011;5; doi: 10.1111/j.1463- 1318.2011.02875.x.
25. Hacker U, Hallek M, Kubicka S. Multimodality therapy of colorectal cancer [article in German]. Internist (Berl). 2010;51(11):1366-1373.